Every Cure

03/12/2025

The lesson of this video is that if you have a rare disease, you need to go to the most experienced centers because in my case even the bus driver could tell I was a Castleman Disease patient when top doctors at other hospitals couldn’t!

02/12/2025

In 2024, Joseph was told he had two choices: die in the hospital or die at home.

Instead, a combination of 3 repurposed drugs identified by our team saved his life.

Every Cure is a nonprofit, and the only way we can continue discovering and delivering these lifesaving repurposed treatments is through your support.

His story is powerful, but it represents something far bigger: there are millions of patients just like Joseph who still don’t have a cure, even though the medicines that could help them may already exist.

On this Giving Tuesday, I hope you’ll go to EveryCure.org/donate as it directly fuels the work that gives patients like Joseph another chance.

27/11/2025

Just days after I arrived at Georgetown, my dad called to tell me my mom had brain cancer.

I rushed home, and within 48 hours she was in a 4.5-hour awake brain surgery — the kind where they open your skull and wake you up mid-procedure so they don’t remove too much and affect your ability to speak.

My sisters, my dad, and I were terrified, just waiting for word that she made it through.

When we finally walked into her room, her head wrapped and a drain bulb beside her, she looked right at us, pointed to her bandage, and said, “Chiquita banana lady.”

After everything she had just endured, her first instinct was to make us laugh.

That moment said everything about who she was — strength, humor, and love all wrapped together.

26/11/2025

21/11/2025

19/11/2025

Hydroxychloroquine and everolimus might stop breast cancer from coming back!

A new Nature Medicine study from Drs. Angela DeMichele and Lewis A. Chodosh at the University of Pennsylvania found that everolimus and hydroxychloroquine—two medicines already approved for other conditions—can dramatically reduce the dormant tumor cells that often cause recurrence.

In this small clinical trial, the combination of both drugs led to an 87% drop in dormant tumor cells and 100% recurrence-free survival at three years for the treated patients.

This is a major step toward targeting cancer before it returns—and a powerful reminder that some of the most promising cures might already be sitting on pharmacy shelves.


25m

19/11/2025

Recently, we learned that the first patient in the U.S., to our knowledge, has been dosed with lidocaine for their breast cancer treatment.

Just six weeks ago, we learned about the potential connection between lidocaine and improved breast cancer outcomes from a groundbreaking clinical trial of 1,600 patients conducted in India.

That study showed a potential 30% reduction in five-year mortality for patients who received lidocaine injections into their tumors before surgery.

Since then, we’ve engaged in discussions with specialists and researchers, and what we’ve discovered has been surprising —no one seemed to be using this approach, despite the data available. The other day, one of those conversations turned into action.

A doctor we spoke to decided to inject a tumor with lidocaine before removing it, marking a critical first step toward translating global insights into real-world patient care.

This moment excites us because it shows the power of accelerating drug repurposing insights into clinical practice. At Every Cure, this is exactly what drives us: identifying overlooked opportunities and ensuring they reach patients who need them most—quickly and efficiently.

13/11/2025